A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor

Dagogo-Jack, I; Moonsamy, P; Gainor, JF; Lennerz, JK; Piotrowska, Z; Lin, JJ; Lennes, IT; Sequist, LV; Shaw, AT; Goodwin, K; Stevens, SE; Do, A; Digumarthy, SR; Price, K; Muzikansky, A; Hata, AN; Heist, RS

Heist, RS (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 32 Fruit St,Yawkey 7B, Boston, MA 02114 USA.

JOURNAL OF THORACIC ONCOLOGY, 2021; 16 (5): 850

Abstract

Introduction: Capmatinib is approved for MET exon 14-altered NSCLC on the basis of activity in targeted therapy-naive patients. We conducted a phase 2......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索